lapatinib,trastuzumab,paclitaxel
novartis
['altto']
a poster #430 a #research project from #neoaltto study is now available at #asco2023! in #bc pts treated with her2-based #neoadjuvant therapy, quantitative analysis of the readily available pre-treatment her2/cep17 ratio by fish predicts pcr but not efs #eu4health 
Breast International Group - Facilitating and accelerating breast cancer research internationally